Effort to improve radiation therapy for veterans receives nearly $4 million

Program monitors quality, safety of therapy at VHA centers nationwide

In a national effort to improve and standardize radiation therapy for U.S. veterans with cancer, the Veterans Health Administration (VHA) has contracted with Washington University School of Medicine in St. Louis for an additional $3.8 million to fund the project.

Federal funding for the effort, which aims to ensure that veterans receive the same high-quality radiation therapy at any of the 40 VHA radiation oncology centers across the country, now totals $4.5 million. The additional funding extends the length of the contract to three years, from one year.

The VHA, part of the U.S. Department of Veterans Affairs, is the country’s largest integrated health-care system, serving more than 8 million veterans each year. The VHA’s National Radiation Oncology Program is coordinating the project.

“This second phase of funding allows us to apply the measures developed last year, to assess care delivered to our veterans,” said Jeff M. Michalski, MD, the Carlos Perez Distinguished Professor of Radiation Oncology and a physician-researcher at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. “Improving outcomes requires defining the quality of care currently provided.”

Along with surgery and chemotherapy, radiotherapy is a major treatment method for a variety of cancer types.

Together with the American Society for Radiation Oncology, Washington University radiation oncologists — physicians at Siteman Cancer Center — have established metrics to assess the quality and safety of each veteran’s cancer therapy.

The new program is called the Radiation Oncology Practice Assessment Program. This year, radiation oncologists are establishing the necessary infrastructure to evaluate quality of care for veterans undergoing treatment for lung and prostate cancers.

Originally published by the Washington University in St Louis School of Medicine



Recent Articles

Oriana Sousa, 28, who lives in Marinha Grande, Portugal, had a rare, aggressive form of ovarian cancer. Traditional trea...
The science of using immunotherapy to treat cancer is advancing rapidly, marked by the National Cancer Institute’s rec...
The science of using immunotherapy to treat cancer is advancing rapidly, marked by the National Cancer Institute’s rec...
A new study identifies genes that are necessary in cancer cells for immunotherapy to work, addressing the problem of why...